Answers are grounded in this paper and cite their sources.
Patients with type 1 diabetes have greater glycemic variability than that in patients with type 2 diabetes. However, neither glucose variability nor hypoglycemia is detected precisely by HbA1c. This study investigated whether glycemic variability assessed by continuous glucose monitoring influences quality of life (QOL) and treatment satisfaction in patients with type 1 diabetes. The study was conducted in Kyoto University Hospital between September 2011 and June 2012. The study protocol was approved by the institutional review board (UMIN Clinical Trials Registry UMI05833). Twenty-eight patients with type 1 diabetes aged ≥18 years were included in analyses (age, 45.9 ± 14.5 [mean ± SD] years; diabetes duration, 15.0 ± 8.2 years; 57% female; 21% using insulin pump; HbA1c, 8.1 ± 1.2% [64.5 ± 13.0 mmol/mol]). Glycemic variability in everyday life was assessed for a 72-h period using the CGMS System Gold continuous glucose …
No takes yet. Share an insight, caveat, or question.
Ayano‐Takahara et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: